• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.瑞典的家族性淀粉样多神经病:系谱分析
J Med Genet. 1993 May;30(5):388-92. doi: 10.1136/jmg.30.5.388.
2
Vitreous involvement in familial amyloidotic neuropathy: a genealogical and genetic study.玻璃体受累于家族性淀粉样变性神经病:一项系谱学和遗传学研究。
Clin Genet. 1991 Dec;40(6):452-60. doi: 10.1111/j.1399-0004.1991.tb03117.x.
3
The first case of familial amyloidotic polyneuropathy (FAP Met30) in the Finnish population.
Hum Hered. 1992;42(3):184-8. doi: 10.1159/000154064.
4
Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis.
Clin Genet. 1988 Mar;33(3):176-80. doi: 10.1111/j.1399-0004.1988.tb03434.x.
5
Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence.瑞典的家族性淀粉样多神经病:地理分布、发病年龄和患病率。
Hum Hered. 1993 Sep-Oct;43(5):288-94. doi: 10.1159/000154146.
6
[Two sibling patients with late-onset familial amyloidotic polyneuropathy and atypical clinical manifestations].
Rinsho Shinkeigaku. 1992 May;32(5):538-40.
7
Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin.无家族发病的家族性淀粉样多神经病:通过放射免疫分析法检测变异型转甲状腺素蛋白携带者
J Neurol Neurosurg Psychiatry. 1988 Apr;51(4):576-8. doi: 10.1136/jnnp.51.4.576.
8
Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders. 2nd International Symposium. Skelleftea, Sweden, June 1-3, 1992. Abstracts.家族性淀粉样多神经病及其他与转甲状腺素蛋白相关的疾病。第二届国际研讨会。瑞典谢莱夫特奥,1992年6月1日至3日。摘要
J Rheumatol. 1993 Jan;20(1):173-98.
9
Amyloidotic polyneuropathy in a Jewish family. Evidence for the genetic heterogeneity of the lower limb familial amyloidotic neuropathies.一个犹太家庭中的淀粉样变性多发性神经病。下肢家族性淀粉样变性神经病遗传异质性的证据。
Q J Med. 1985 Apr;55(216):33-44.
10
Familial amyloidotic polyneuropathy: report of patients heterozygous for the transthyretin Gly42 gene.家族性淀粉样多神经病:转甲状腺素蛋白Gly42基因杂合子患者报告
Ann Neurol. 1992 Mar;31(3):340-2. doi: 10.1002/ana.410310319.

引用本文的文献

1
Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability.遗传性转甲状腺素蛋白淀粉样变性:影响表型变异性的众多因素。
J Neurol. 2024 Sep;271(9):5746-5761. doi: 10.1007/s00415-024-12509-8. Epub 2024 Jun 22.
2
Sex Differences in Transthyretin Cardiac Amyloidosis: Unraveling the Complexities in Epidemiology, Pathophysiology, Diagnosis, and Treatment.转甲状腺素蛋白心脏淀粉样变中的性别差异:揭示流行病学、病理生理学、诊断和治疗中的复杂性。
Curr Heart Fail Rep. 2024 Aug;21(4):344-353. doi: 10.1007/s11897-024-00667-9. Epub 2024 May 22.
3
Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.马略卡岛 V30M 变异转甲状腺素蛋白淀粉样变病(A-ATTRv)的疾病风险估计。
Orphanet J Rare Dis. 2023 Aug 31;18(1):255. doi: 10.1186/s13023-023-02865-5.
4
Study of the parent-of-origin effect in monogenic diseases with variable age of onset. Application on ATTRv.研究发病年龄可变的单基因疾病中的母源效应。在 ATTRv 上的应用。
PLoS One. 2023 Aug 10;18(8):e0288958. doi: 10.1371/journal.pone.0288958. eCollection 2023.
5
Clinical model for Hereditary Transthyretin Amyloidosis age of onset prediction.遗传性转甲状腺素蛋白淀粉样变性病发病年龄预测的临床模型。
Front Neurol. 2023 Jul 17;14:1216214. doi: 10.3389/fneur.2023.1216214. eCollection 2023.
6
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.载脂蛋白 A97 丝氨酸转甲状腺素蛋白淀粉样变性相关性多发性神经病:泰国队列的临床和神经生理学特征。
BMC Neurol. 2021 May 22;21(1):206. doi: 10.1186/s12883-021-02243-3.
7
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.女性转甲状腺素蛋白淀粉样心肌病:频率、特征和诊断挑战。
Heart Fail Rev. 2021 Jan;26(1):35-45. doi: 10.1007/s10741-020-10010-8.
8
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy.他法米地作为转甲状腺素蛋白家族性淀粉样多神经病一线治疗药物的评估。
Degener Neurol Neuromuscul Dis. 2012 Oct 19;2:165-173. doi: 10.2147/DNND.S24624. eCollection 2012.
9
Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases.墨西哥因转甲状腺素蛋白(TTR)突变导致的淀粉样变性,索引病例中有4种不同基因型。
Orphanet J Rare Dis. 2018 Jul 3;13(1):107. doi: 10.1186/s13023-018-0801-y.
10
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.转甲状腺素蛋白 V122I(pV142I)*心脏淀粉样变性:一种与年龄相关的常染色体显性遗传性心肌病,在老年非裔美国人中因显著心脏病而被忽视的常见病因。
Genet Med. 2017 Jul;19(7):733-742. doi: 10.1038/gim.2016.200. Epub 2017 Jan 19.

本文引用的文献

1
A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.一种特殊形式的周围神经病变;家族性非典型全身性淀粉样变性,周围神经有特殊受累情况。
Brain. 1952 Sep;75(3):408-27. doi: 10.1093/brain/75.3.408.
2
Studies on familial amyloid polyneuropathy in Ogawa Village, Japan.日本小川村家族性淀粉样多神经病的研究。
Eur Neurol. 1980;19(3):141-51. doi: 10.1159/000115139.
3
Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).家族性淀粉样多神经病(日本型)中淀粉样前白蛋白变异体的鉴定。
Biochem Biophys Res Commun. 1983 Nov 15;116(3):880-8. doi: 10.1016/s0006-291x(83)80224-1.
4
Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.葡萄牙家族性淀粉样多神经病患者中异常转甲状腺素蛋白(前白蛋白)的存在。
Trans Assoc Am Physicians. 1983;96:261-70.
5
Familial correlations for age at onset and age at death in Huntington's disease.亨廷顿舞蹈症发病年龄与死亡年龄的家族相关性。
J Med Genet. 1972 Mar;9(1):23-32. doi: 10.1136/jmg.9.1.23.
6
Structurally abnormal transthyretin causing familial amyloidotic polyneuropathy in Sweden.在瑞典,结构异常的转甲状腺素蛋白导致家族性淀粉样多神经病。
Clin Chim Acta. 1987 Aug 31;167(3):341-2. doi: 10.1016/0009-8981(87)90355-x.
7
Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden.
Acta Med Scand Suppl. 1976;590:1-64.

瑞典的家族性淀粉样多神经病:系谱分析

Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

作者信息

Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A

机构信息

Research Archives, University of Umeå, Sweden.

出版信息

J Med Genet. 1993 May;30(5):388-92. doi: 10.1136/jmg.30.5.388.

DOI:10.1136/jmg.30.5.388
PMID:8100581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1016374/
Abstract

Extended genealogical studies were performed on the heredity patterns in Swedish patients with familial amyloidotic polyneuropathy (FAP) using Swedish historical archives. The population studied included 239 patients: 109 patients were linked to five large pedigrees and 80 patients belonged to 30 smaller pedigrees or nuclear families. In the remaining 50 cases, no genealogical links were found. Differences in mean ages of onset between the different pedigrees were found, although a considerable variation within the pedigrees was also present. There was a tendency for later ages of onset among older generations than younger ones: descendants of affected mothers seem to be more prone to anticipation in age of onset than descendants of affected fathers. Furthermore, there seems to be a tendency for earlier ages of onset among patients with a carrier mother than a carrier father. Some extended pedigrees, from the Skellefteå and Piteå areas, are presented in detail. The former go back into the middle of the 17th century. One important conclusion is that the mutational event may have occurred in late mediaeval times.

摘要

利用瑞典历史档案对瑞典家族性淀粉样多神经病(FAP)患者的遗传模式进行了广泛的系谱研究。所研究的人群包括239名患者:109名患者与五个大型家系有关联,80名患者属于30个较小的家系或核心家庭。在其余50例中,未发现系谱关联。不同家系之间发现了发病平均年龄的差异,尽管家系内部也存在相当大的变异。老一代的发病年龄有比年轻一代晚的趋势:受影响母亲的后代在发病年龄上似乎比受影响父亲的后代更容易出现发病年龄提前的情况。此外,携带母亲的患者似乎比携带父亲的患者有发病年龄更早的趋势。详细介绍了来自谢莱夫特奥和皮特奥地区的一些大型家系。前者可追溯到17世纪中叶。一个重要的结论是,突变事件可能发生在中世纪晚期。